Bio-Rad Laboratories, Inc. BIO
360.26 USD -6.10 (-1.67%)
Regular-session close
360.26 0.00 0.00%
After hours · Nov 16, 4:05 PM ET
358.64 Day range 365.61
241.71 52-week range 390.34
- YTD
- +18.90%
- 1 year
- +15.04%
News
defenseworld.net Insider Selling: Bio-Rad Laboratories (NYSE:BIO) EVP Sells $539,882.00 in Stock Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction on Monday, November 9th. The shares were sold at an average price of…
defenseworld.net Bio-Rad Laboratories (NYSE:BIO) Stock: Insider Courtney Enloe Sells 902 Shares Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP Courtney Enloe sold 902 shares of the company's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average…
defenseworld.net Bio-Rad Laboratories (NYSE:BIO) Stock: Insider Jonathan Divincenzo Sells 919 Shares Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) COO Jonathan Divincenzo sold 919 shares of the stock in a transaction that occurred on Monday, November 9th. The shares were sold at an…
defenseworld.net Bio-Rad Laboratories (NYSE:BIO) Stock: Insider James Barry Sells 1,400 Shares Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction dated Monday, November 9th. The stock was sold at an average price…
defenseworld.net Bio-Rad Laboratories, Inc. $BIO Stock Sold by Fisher Asset Management LLC Fisher Asset Management LLC lessened its position in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1.9% during the third quarter, according to its most recent filing with the Securities and…
globenewswire.com BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe; Hosts Call Today at 10am ET HOLMDEL, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today…
globenewswire.com BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE KUALA LUMPUR, MALAYSIA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety…
globenewswire.com BIO-key Enters Gaming / Hospitality Market with Contract from Major U.S. Casino Resort BIO-key entered gaming & hospitality market with contract from major U.S. casino resort to deploy PortalGuard® IAM platform and Identity-Bound Biometrics.
seekingalpha.com Bio-Rad Laboratories, Inc. (BIO) Presents at 2026 UBS Global Healthcare Conference Transcript Bio-Rad Laboratories, Inc. ( BIO ) 2026 UBS Global Healthcare Conference November 10, 2026 8:00 AM EST Company Participants Roop Lakkaraju - Executive VP & CFO Conference Call Participants Douglas…
globenewswire.com Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Alpha-Lactalbumin for Premium Nutrition Markets in the U.S. Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Al
zacks.com Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention Examine the evolution of Bio-Rad's (BIO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.benzinga.com RBC Capital Maintains Outperform on Bio-Rad Laboratories, Raises Price Target to $440 RBC Capital analyst Dan Leonard maintains Bio-Rad Laboratories (NYSE:BIO) with a Outperform and raises the price target from $390 to $440.
globenewswire.com Medicus Pharma to Present at BIO-Europe 2026 Medicus Chief Medical Officer will Highlight Company's Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs Medicus Chief Medical Officer will Highlight…
marketbeat.com What Bio-Rad Laboratories (BIO) Said on Its Q3 Earnings Call Bio-Rad Laboratories NYSE: BIO reported modest third-quarter revenue growth, its first currency-neutral increase of 2026, as gains in clinical diagnostics and digital PCR instruments helped offset…
seekingalpha.com Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript
zacks.com Bio-Rad Laboratories (BIO) Q3 Earnings Top Estimates Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.65 per share, beating the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.26 per share a year ago.
benzinga.com Bio-Rad Laboratories Q3 2026 Earnings Call Transcript Bio-Rad Laboratories (NYSE:BIO) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Bio-Rad Laboratories Affirms FY2026 Sales Guidance of $2.506B-$2.596B vs $2.588B Est Bio-Rad Laboratories (NYSE:BIO) affirms FY2026 sales outlook from $2.506 billion-$2.596 billion to $2.506 billion-$2.596 billion vs $2.588 billion estimate.
benzinga.com Bio-Rad Laboratories Q3 Adj. EPS $2.65 Beats $2.23 Estimate, Sales $656.400M Beat $649.950M Estimate Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.65 per share which beat the analyst consensus estimate of $2.23 by 18.83 percent. This is a 17.26 percent increase over earnings of…
businesswire.com Bio-Rad Reports Third-Quarter 2026 Financial Results HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for…
prnewswire.com BIO-TECHNE DECLARES DIVIDEND MINNEAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September…
globenewswire.com Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal Cipher, a Prosegur Company, and BIO-key (BKYI) Announce Technology Integration to Expand Identity Security Offering Internationally, Starting in Portugal.
businesswire.com Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief…
globenewswire.com BIO-key Deploys Identity Security Solution to New Customer Within a Middle East Government's National Security Ecosystem RIYADH, Saudi Arabia and HOLMDEL, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global provider of Identity and Access Management (IAM) and biometric…
